Skip to main content

Advertisement

Table 2 Histological characteristics of the patient population

From: An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study

  Hepatitis B patients Hepatitis C patients
Liver biopsy features Baseline liver biopsy Liver Biopsy after treatment Baseline liver biopsy Liver Biopsy after treatment
HAI*1 8(3,13)*1 4 (0,12)*1 7 (2,14)*1 4 (0,9)*1
0–8 N(%) 11(44) 18 (78.26) 16 (64) 10 (77)
9–12 N(%) 13 (52) 5 (21.74) 8 (32) 3 (23)
> 12 N(%) 1 (4) 0 1 (4) 0
Fibrosis 4 (1,6) 2 (0,6) 3 (1,6) 2 (0,6)
Cirrhosis N(%)*2 9 (36) 5 (21.74) 5 (20) 3 (23)
Steatosis*3 0(0,1) 4 (0,12) 0 (0,3) 0 (0,1)
No steatosis N(%) 16(64) 19 (82.61) 13 (54.17) 12 (92.3)
Mild N(%) 9 (36) 4 (17.39) 10 (41.67) 1(7.69)
Moderate N (%) 0 0 0 0
Severe N (%) 0 0 1 (4.17) 0
  1. *1Histological activity (HAI), fibrosis and steatosis data ere expressed as median (range).
  2. *2 Cirrhosis: Stage of fibrosis 5&6 (Ishak classification system)
  3. *3 Steatosis: Mild: < 33% of hepatocytes affected; Moderate: 33% to 66% of hepatocytes affected; Severe: > 66% of hepatocytes affected.